From: Quality indicators for acute cardiovascular diseases: a scoping review
Quality indicator | Clinical setting | Donabedian framework | Definition of quality indicator (representative) | Number of publications [reference] |
---|---|---|---|---|
Beta-blocker therapy for HFrEF | During hospitalization / at discharge | Process | Patients prescribed beta-blocker therapy/patients with HFrEF | |
ACE inhibitor, ARB or ARNI therapy for HFrEF | During hospitalization / at discharge | Process | Patients prescribed ACEi, ARB, or ARNI therapy/patients with HFrEF | |
Assessment of LV function | During hospitalization / at discharge | Process | Patients who underwent assessment of LV function/patients with HF | |
Patient education | During hospitalization / at discharge | Process | Percentage of patients with HF and family members who received education regarding HF management | |
Short or long-term mortality or readmission | – | Outcome | The proportion of mortality or HF readmission within 30 days or 1 year after discharge |